Diamonds and Dogs
Target (TGT) is on target. Retailer Target (TGT) is up 11% after reporting a monster quarter. Profits jump 80% as same store sales set a record. E-commerce services saw dramatic growth attracting 10 million new digital customers while picking up $5 billion in market share in the first half of the year. Curbside pickup service jumping by more than 700%.
Gilead Sciences (GILD) can't seem to get out of its own way. The drug company is down 3% to a five-month low after the U.S. FDA declined to approve its experimental rheumatoid arthritis treatment, a major setback for one of the drug maker's important products. Gilead's antiviral medicine remdesivir has put the company at the forefront of the fight against the COVID-19 pandemic.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.